2023 - Research.com Medicine in France Leader Award
2023 - Research.com Biology and Biochemistry in France Leader Award
2006 - Grand prix de l'Inserm - Institut national de la santé et de la recherche médicale
2003 - Member of the European Academy of Sciences
1998 - Fellow of the American Academy of Arts and Sciences
1990 - Member of Academia Europaea
Pierre Corvol mainly investigates Internal medicine, Endocrinology, Angiotensin II, Renin–angiotensin system and Biochemistry. The study incorporates disciplines such as Pharmacology and In vivo in addition to Internal medicine. His Endocrinology research includes elements of Receptor and In situ hybridization.
His Angiotensin II research integrates issues from Hypothalamus and Signal transduction. As a member of one scientific family, he mostly works in the field of Renin–angiotensin system, focusing on Kidney and, on occasion, Pathology. His study focuses on the intersection of Enzyme and fields such as Angiotensin-converting enzyme with connections in the field of Molecular biology, Gene targeting, Gene, Chinese hamster ovary cell and Molecular cloning.
Internal medicine, Endocrinology, Renin–angiotensin system, Biochemistry and Angiotensin II are his primary areas of study. His study in Plasma renin activity, Blood pressure, Kidney, Angiotensin-converting enzyme and Essential hypertension is carried out as part of his Internal medicine studies. The various areas that Pierre Corvol examines in his Blood pressure study include Surgery and Cardiology.
His Endocrinology research incorporates elements of Receptor, In situ hybridization and Cell biology. The Renin–angiotensin system study combines topics in areas such as Molecular biology, Radioimmunoassay, Antibody and Pharmacology. His work deals with themes such as Complementary DNA, Gene expression, Messenger RNA and Gene, which intersect with Molecular biology.
His primary scientific interests are in Internal medicine, Endocrinology, Renin–angiotensin system, Angiotensin II and Angiogenesis. He interconnects Missense mutation and In situ hybridization in the investigation of issues within Internal medicine. His Endocrinology study combines topics in areas such as Mutation, Receptor and In vivo.
His Renin–angiotensin system research is multidisciplinary, relying on both Fetus, Kidney, Pharmacology and Cell biology. Pierre Corvol has researched Angiotensin II in several fields, including Aldosterone, Bradykinin and Enzyme. His work on ACE inhibitor as part of general Angiotensin-converting enzyme study is frequently connected to Angiotensin-converting enzyme 2, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
Pierre Corvol spends much of his time researching Internal medicine, Endocrinology, Renin–angiotensin system, Angiogenesis and Angiotensin II. His studies deal with areas such as Surgery and Cell growth as well as Internal medicine. His Endocrinology research is multidisciplinary, incorporating perspectives in Receptor, Chinese hamster ovary cell and In vivo.
The various areas that he examines in his Renin–angiotensin system study include Kidney, Anuria and Potter sequence. His Angiogenesis study combines topics from a wide range of disciplines, such as Endothelial stem cell, Vascular endothelial growth factor and In situ hybridization. His Angiotensin II research includes themes of Aldosterone, Angiotensin-converting enzyme, Bradykinin and Enzyme.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.
B Rigat;C Hubert;F Alhenc-Gelas;F Cambien.
Journal of Clinical Investigation (1990)
Molecular basis of human hypertension: Role of angiotensinogen
Xavier Jeunemaitre;Florent Soubrier;Yuri V. Kotelevtsev;Richard P. Lifton;Richard P. Lifton.
PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1)
Brigitte Rigat;Christine Hubert;Pierre Corvol;Florent Soubrier.
Nucleic Acids Research (1992)
Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels.
L Tiret;B Rigat;S Visvikis;C Breda.
American Journal of Human Genetics (1992)
Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension.
Alain Bonnardeaux;Eleanor Davies;Xavier Jeunemaitre;Isabelle Fery.
Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning.
Florent Soubrier;Francois Alhenc-Gelas;Christine Hubert;Jacqueline Allegrini.
Proceedings of the National Academy of Sciences of the United States of America (1988)
Mutations in the SDHB Gene Are Associated with Extra-adrenal and/or Malignant Phaeochromocytomas
Anne-Paule Gimenez-Roqueplo;Judith Favier;Pierre Rustin;Claudine Rieubland.
Cancer Research (2003)
Structure of the angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene.
Christine Hubert;Anne-Marie Houot;Pierre Corvol;Florent Soubrier.
Journal of Biological Chemistry (1991)
The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway.
Anne-Paule Gimenez-Roqueplo;Judith Favier;Pierre Rustin;Jean-Jacques Mourad.
American Journal of Human Genetics (2001)
Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis.
Judith C. Sluimer;Jean-Marie Gasc;Job L. van Wanroij;Natasja Kisters.
Journal of the American College of Cardiology (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: